Posts Tagged 'targeted therapies'
Biospecimens in personalized medicine are a cornerstone for its future development and establishment as a real-life clinical practice. And yet, the crucial role of biosamples and the process of their ethical collection are not well understood. As a biospecimen provider, we consider it part of our mission to educate and raise awareness on this topic. …Read More
Every September, the world marks Blood Cancer Awareness Month. This year, Audubon Bioscience joined the initiative and its efforts to inform patients about this variable group of malignant pathologies. We support the campaign with this article, which briefly overviews the different types of blood cancers, the most common risk factors, and symptoms, allowing for early…Read More
Medical professionals support biobanking by identifying, informing, and protecting the patients willing to donate biosamples to research. Biospecimen procurement relies strongly on all medical staff involved in the process of patient engagement and correct biosample collection. It is therefore, extremely important to understand, appreciate and raise awareness of the importance medical professionals have in…Read More
March 16, 2021 Over the last two decades, oncology research has achieved outstanding results in the way we understand and approach the multifaceted nature of cancer. From immuno-oncology at the forefront to targeted therapies and biomarkers identification, novel therapeutic multiplicity is impressive. Despite their diversification, these therapies have few crucial commonalities: they are targeted, personalized,…Read More